Advanced Filters
noise
Found 65,447 clinical trials
M Muhammad Asif Javed, MS

Modified Constraint Induced Movement Therapy Versus Virtual Reality Training in Children With Cerebral Palsy

Children with hemiplegic cerebral palsy (CP) are characterized by motor impairments mainly lateralized to one side of the body, with greater upper limb than lower limb involvement; these impairments may further limit the daily activities and school participation of children with hemiplegic CP. For the improvement of activity limitations in …

6 - 12 years of age All Phase N/A
J Jinming Yu, PhD

SKB445 for Injection in Solid Tumors

This is a multicenter, open-label, multiple-dose dose finding and expansion study to evaluate the safety, tolerability, pharmacokinetic(PK) profile, and anti-tumor efficacy of SKB445 for injection in patients with advanced solid tumors.

18 - 75 years of age All Phase 1
D Dena Berci, MN

DOnor Milk to REpair the Full-term Infant MIcrobiome in Infants Born Via Cesarean Section.

The objective of this novel study is to establish proof of concept using a pilot randomized controlled trial to determine the effect of DHM compared to formula supplementation on the microbiome in full-term infants who are born via caesarean section and require supplementation. Secondarily, this study aims to compare the …

37 years of age All Phase N/A
R Raffaella Aldigeri, Dr

Food (poly)phenol Metabotypes and Beta-cell Mass and Function.

Cross-sectional, single-centre, 'low intervention' clinical study, without drug or medical device testing, with low-risk diagnostic technique.

18 years of age All Phase N/A
G Gang Wang

Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder

This is a randomized double-blind placebo-controlled phase 3 clinical trial to further validate the effectiveness and safety of Shugan Jieyu Capsules in treating generalized anxiety disorder.

18 - 65 years of age All Phase 3
S Sara L. Peterson, PhD

Detecting Change in Muscle Parameters, Pain, and Function with NMES for TTA

The proposal aims to investigate a non-invasive, cost-effective method for rebuilding muscle mass in individuals with transtibial limb loss. Maintaining a healthy, pain-free residual limb is a primary concern for prosthesis users. Amputees commonly experience muscle deficits leading to mobility issues, poor prosthetic fit, and chronic pain. Neuromuscular electrical stimulation …

18 - 100 years of age All Phase N/A
B Bo Liu

IB-T101 Injection for Treatment of Patients with Advanced Clear Cell Renal Cell Carcinoma

This is an open label, single center, dose escalation, and dose extension IIT study aimed at evaluating the safety, efficacy, and pharmacokinetics of IB-T101 in adult patients with advanced clear renal cell carcinoma

18 years of age All Phase 1
S Shih-Chun Kao, PhD

Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children

The goal of this randomized cross-over trial is to learn about the effect of a single bout of 20-min mindfulness-based high-intensity interval training (MF-HIIT), MF-only, and HIIT-only in relative to sitting rest on executive function (EF) in 10-12 years old children. The main question it aims to answer are: Question …

10 - 12 years of age All Phase N/A
K Kristen K Ellard, PhD

Intermittent Theta Burst Stimulation (iTBS) for Emotion Regulation in Bipolar Disorder

The objective of this study protocol is to test whether intermittent theta-burst transcranial magnetic stimulation (iTBS-TMS) to the inferior parietal lobule (IPL) can strengthen functional connectivity with a key region in emotion regulation (ER) neurocircuitry (anterior insula, AI) and improve performance on ER-related tasks in patients with bipolar disorder. Individual …

24 - 65 years of age All Phase N/A

A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

This is a Phase 1, first-in-human, open-label, multi-center study with the aim of exploring the safety, tolerability, PK, and preliminary anti-tumor activity of ANS014004 as a single agent in participants with locally advanced or metastatic solid tumors.

18 years of age All Phase 1

Simplify language using AI